tizanidine
- Product NDC
- 68788-4159
- 11-digit product format
- 687884159
- Labeler code
- 68788
- Product ID
- 68788-4159_8d0b2b22-e1df-4ad5-92e6-f9a369108e4b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals Inc.
- Application
- ANDA218920
- Marketing category
- ANDA
- Marketing start
- 2026-07-16
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218920-001 | TIZANIDINE HYDROCHLORIDE | TIZANIDINE HYDROCHLORIDE | EQ 2MG BASE | TABLET / ORAL | AB | 2024-08-07 | |
| A218920-002 | TIZANIDINE HYDROCHLORIDE | TIZANIDINE HYDROCHLORIDE | EQ 4MG BASE | TABLET / ORAL | AB | 2024-08-07 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A218920-001 | AB |
| A218920-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A218920-001 | TIZANIDINE HYDROCHLORIDE | EQ 2MG BASE | TABLET / ORAL | AB | 2024-08-07 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A218920-002 | TIZANIDINE HYDROCHLORIDE | EQ 4MG BASE | TABLET / ORAL | AB | 2024-08-07 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A218920-001 | TIZANIDINE HYDROCHLORIDE | EQ 2MG BASE | TABLET / ORAL | AB | 2024-08-07 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A218920-002 | TIZANIDINE HYDROCHLORIDE | EQ 4MG BASE | TABLET / ORAL | AB | 2024-08-07 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A218920-001 | TIZANIDINE HYDROCHLORIDE | EQ 2MG BASE | TABLET / ORAL | AB | 2024-08-07 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A218920-002 | TIZANIDINE HYDROCHLORIDE | EQ 4MG BASE | TABLET / ORAL | AB | 2024-08-07 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218920-001 | TIZANIDINE HYDROCHLORIDE | EQ 2MG BASE | TABLET / ORAL | AB | 2024-08-07 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218920-002 | TIZANIDINE HYDROCHLORIDE | EQ 4MG BASE | TABLET / ORAL | AB | 2024-08-07 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A218920-001 | TIZANIDINE HYDROCHLORIDE | EQ 2MG BASE | TABLET / ORAL | AB | 2024-08-07 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A218920-002 | TIZANIDINE HYDROCHLORIDE | EQ 4MG BASE | TABLET / ORAL | AB | 2024-08-07 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A218920-001 | TIZANIDINE HYDROCHLORIDE | EQ 2MG BASE | TABLET / ORAL | AB | 2024-08-07 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A218920-002 | TIZANIDINE HYDROCHLORIDE | EQ 4MG BASE | TABLET / ORAL | AB | 2024-08-07 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A218920-001 | TIZANIDINE HYDROCHLORIDE | EQ 2MG BASE | TABLET / ORAL | AB | 2024-08-07 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A218920-002 | TIZANIDINE HYDROCHLORIDE | EQ 4MG BASE | TABLET / ORAL | AB | 2024-08-07 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A218920-001 | TIZANIDINE HYDROCHLORIDE | EQ 2MG BASE | TABLET / ORAL | AB | 2024-08-07 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A218920-002 | TIZANIDINE HYDROCHLORIDE | EQ 4MG BASE | TABLET / ORAL | AB | 2024-08-07 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A218920-001 | TIZANIDINE HYDROCHLORIDE | EQ 2MG BASE | TABLET / ORAL | AB | 2024-08-07 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A218920-002 | TIZANIDINE HYDROCHLORIDE | EQ 4MG BASE | TABLET / ORAL | AB | 2024-08-07 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A218920-001 | TIZANIDINE HYDROCHLORIDE | EQ 2MG BASE | TABLET / ORAL | AB | 2024-08-07 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A218920-002 | TIZANIDINE HYDROCHLORIDE | EQ 4MG BASE | TABLET / ORAL | AB | 2024-08-07 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A218920-001 | TIZANIDINE HYDROCHLORIDE | EQ 2MG BASE | TABLET / ORAL | AB | 2024-08-07 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A218920-002 | TIZANIDINE HYDROCHLORIDE | EQ 4MG BASE | TABLET / ORAL | AB | 2024-08-07 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A218920-001 | TIZANIDINE HYDROCHLORIDE | EQ 2MG BASE | TABLET / ORAL | AB | 2024-08-07 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A218920-002 | TIZANIDINE HYDROCHLORIDE | EQ 4MG BASE | TABLET / ORAL | AB | 2024-08-07 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A218920-001 | TIZANIDINE HYDROCHLORIDE | EQ 2MG BASE | TABLET / ORAL | AB | 2024-08-07 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A218920-002 | TIZANIDINE HYDROCHLORIDE | EQ 4MG BASE | TABLET / ORAL | AB | 2024-08-07 | 79d66fd596c7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218920-001 | TIZANIDINE HYDROCHLORIDE | EQ 2MG BASE | TABLET / ORAL | AB | 2024-08-07 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218920-002 | TIZANIDINE HYDROCHLORIDE | EQ 4MG BASE | TABLET / ORAL | AB | 2024-08-07 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A218920-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A218920-002 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A218920-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A218920-002 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A218920-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A218920-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218920-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218920-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A218920-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A218920-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A218920-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A218920-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A218920-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A218920-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A218920-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A218920-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A218920-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A218920-002 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A218920-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A218920-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A218920-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A218920-002 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A218920-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A218920-002 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A218920-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A218920-002 | AB | 1 | 79d66fd596c7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218920-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218920-002 | AB | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- tizanidine
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TIZANIDINE HYDROCHLORIDE | 4 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| B53E3NMY5C | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 313413 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 8d0b2b22-e1df-4ad5-92e6-f9a369108e4b | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| tizanidine | TIZANIDINE | Preferred Pharmaceuticals Inc. | 8d0b2b22-e1df-4ad5-92e6-f9a369108e4b | 2026-07-16 | Warnings, Adverse reactions | 218920 ANDA218920 68788-4159 |
| tizanidine | TIZANIDINE | A-S Medication Solutions | 52830423-0430-410e-93af-169dc11b3565 | 2025-10-17 | Warnings, Adverse reactions | 218920 ANDA218920 |
| tizanidine | TIZANIDINE | Rising Pharma Holdings, Inc. | 433ac98f-ac22-44ad-a8b4-5db5560b9d0f | 2025-08-14 | Warnings, Adverse reactions | 218920 ANDA218920 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 68788-4159-1 | 68788415901 | 100 TABLET in 1 BOTTLE (68788-4159-1) | 100 tablet | 2026-07-16 | No | No | Current |
| 68788-4159-2 | 68788415902 | 20 TABLET in 1 BOTTLE (68788-4159-2) | 20 tablet | 2026-07-16 | No | No | Current |
| 68788-4159-3 | 68788415903 | 30 TABLET in 1 BOTTLE (68788-4159-3) | 30 tablet | 2026-07-16 | No | No | Current |
| 68788-4159-6 | 68788415906 | 60 TABLET in 1 BOTTLE (68788-4159-6) | 60 tablet | 2026-07-16 | No | No | Current |
| 68788-4159-8 | 68788415908 | 120 TABLET in 1 BOTTLE (68788-4159-8) | 120 tablet | 2026-07-16 | No | No | Current |
| 68788-4159-9 | 68788415909 | 90 TABLET in 1 BOTTLE (68788-4159-9) | 90 tablet | 2026-07-16 | No | No | Current |